The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2023 | Personalized medicine in mesothelioma
Dean Fennell, FRCP, PHD, University Hospitals of Leicester NHS Trust, Leicester, UK, discusses precision medicine in mesothelioma, highlighting the main challenges associated with the implementation of personalized medicine, including the prevalence of tumor suppressor genes which are not typically associated as druggable targets, as well as the potential of umbrella trials in mesothelioma. This interview took place at the European Lung Cancer Congress 2023 in Copenhagen, Denmark.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
